The association between serum potassium and mortality in patients with hypertension: ‘a wake-up call’
Authors:
- 7 July 2016
- journal article
- editorial
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 38 (2) , ehw209-115
Abstract
This editorial refers to ‘Short-term mortality risk of serum potassium levels in hypertension: a retrospective analysis of nationwide registry data’, by M. Krogager et al . doi:10.1093/eurheartj/ehw129 There has been considerable focus on the risks of hyperkalaemia, especially in patients with chronic kidney disease (CKD), diabetes mellitus, and/or heart failure.1–3 Although the exact level of serum potassium (K+) that is associated with an increase in mortality remains controversial, increasing evidence suggests that in patients with CKD, diabetes mellitus, and/or heart failure, especially the elderly, a K+ >5.0 mmol/L is associated with an increased risk of death.4 Conversely, while a K+ 40 000 patients with hypertension taking a dual single antihypertensive drug. Patients with renal insufficiency, those with missing …Keywords
This publication has 14 references indexed in Scilit:
- A Randomized Trial of Intensive versus Standard Blood-Pressure ControlNew England Journal of Medicine, 2015
- New Potassium Binders for the Treatment of HyperkalemiaHypertension, 2015
- Predictors of Hyperkalemia and Death in Patients With Cardiac and Renal DiseaseThe American Journal of Cardiology, 2012
- The Role of Aldosterone in the Metabolic SyndromeCurrent Hypertension Reports, 2011
- Ion-Exchange Resins for the Treatment of HyperkalemiaJournal of the American Society of Nephrology, 2010
- Hypokalemia and Outcomes in Patients With Chronic Heart Failure and Chronic Kidney DiseaseCirculation: Heart Failure, 2010
- Effect of Spironolactone on Left Ventricular Mass and Aortic Stiffness in Early-Stage Chronic Kidney DiseaseJACC, 2009
- A propensity-matched study of the association of low serum potassium levels and mortality in chronic heart failureEuropean Heart Journal, 2007
- Managing Hyperkalemia Caused by Inhibitors of the Renin–Angiotensin–Aldosterone SystemNew England Journal of Medicine, 2004
- DASH (Dietary Approaches to Stop Hypertension) Diet Is Effective Treatment for Stage 1 Isolated Systolic HypertensionHypertension, 2001